{'fraction_non_alphanumeric': 0.03759549083001917, 'fraction_numerical': 0.018025235329461247, 'mean_word_length': 5.385093167701863, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 3, 'https://': 7, 'lorem ipsum': 0, 'www.': 2, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Disease-Associated Circular RNAs: From Biology to Computational Identification

Circular RNAs (circRNAs) are endogenous RNAs with a covalently closed continuous loop, generated through various backsplicing events of pre-mRNA. An accumulating number of studies have shown that circRNAs are potential biomarkers for major human diseases such as cancer and Alzheimer's disease. Thus, identification and prediction of human disease-associated circRNAs are of significant importance. To this end, a computational analysis-assisted strategy is indispensable to detect, verify, and quantify circRNAs for downstream applications. In this review, we briefly introduce the biology of circRNAs, including the biogenesis, characteristics, and biological functions. In addition, we outline about 30 recent bioinformatic analysis tools that are publicly available for circRNA study. Principles for applying these computational strategies and considerations will be briefly discussed. Lastly, we give a complete survey on more than 20 key computational databases that are frequently used. To our knowledge, this is the most complete and updated summary on publicly available circRNA resources. In conclusion, this review summarizes key aspects of circRNA biology and outlines key computational strategies that will facilitate the genome-wide identification and prediction of circRNAs.


Introduction
Circular RNAs (circRNAs) are traditionally viewed as noncoding RNAs that form a covalently closed continuous loop and thought to be generated from imperfect splicing. However, emerging evidence has shown a complexity of cir-cRNAs in gene expression regulation, and thus the notion that circRNAs are of low abundance has been gradually challenged. Thus, the generation of circRNAs from such noncanonical RNA splicing appears to be a feature of human gene expression [1].
In the present review, we will briefly introduce the biology of circRNAs, including the biogenesis process, classification, and characteristics. Given that the biological function and mechanisms of gene regulation of circRNAs are not fully understood, we will summarize what has been widely acknowledged. In addition, since several features of cir-cRNAs, including circular conformation, relatively low abundance, and overlap in sequence with other RNA counterparts, often hinder the investigation of circRNAs, we will then describe recent progress in computational strategies for identification and prediction of circRNAs. In contrast to benchmarking the strategies, we aim to give the readers a board introduction of circRNA biology and computational method, which will help them in designing their future studies and analyzing results. Readers interested in specific topics should refer to the reviews on circRNAs that have been summarized elsewhere [23][24][25][26][27].

Discovery of circRNAs
circRNAs were initially discovered via electron microscopy as a viroid in the mid-70s, because of the circular conformation [28,29]. The biological analysis found that these cir-cRNAs show several features, including (1) single-stranded, (2) high thermal stability, (3) self-complementarity in a rod-like structure, and (4) covalently closed as a loop [28]. Later, in the 90s, owing to advancement in computational biology and RNA sequencing, researchers finally determined the structure of the previously identified transcripts that show an inverted order of exons that is distinct from genomic DNA, which was mistakenly recognized as RNA splicing errors [30]. This study found that, although these transcripts are nonpolyadenylated and not as abundant as in a normal transcript, they are stable molecules and expressed in the cytoplasmic part of the cells [30]. Tumorsuppressor circRNA sponges contain binding sites for tumor-suppressor miRNAs (light purple), while oncogenic circRNA sponges contain binding sites for oncogenic miRNAs (red). Tumor-suppressor circRNAs upregulate tumor-suppressor genes (yellow) in healthy tissues but downregulate these genes in tumor tissues, whereas oncogenic circRNAs suppress oncogene (green) expression in healthy tissues but upregulate these genes in tumor tissues. AGO: Argonaute; RBP: RNA-binding protein. Illustration is inspired by and modified from [164]. (d) New studies suggest that circRNAs generated by backsplicing are able to be translated into proteins. Illustration is modified from [38,39]. Illustrations were generated using BioRender. 2 BioMed Research International The breakthrough in high-throughput sequencing (HTS) technology in the 21st century made it possible to deepen our understanding of circRNA sequences and functionality. In 2012, using deep RNA sequencing (RNA-seq) of normal and cancer stem cells from human samples, circRNAs were identified from a substantial fraction of spliced precursor message RNAs (pre-mRNAs) that showed a noncanonical order [1], suggesting a new feature of the gene expression program in human cells. Later, a close examination of cir-cRNAs using Circle-Seq found that these molecules usually consist of up to five exons; however, each of them can be three times longer than the average expressed exon [31,32]. A computational strategy was developed to specifically detect circRNAs, enabling identification of thousands of stable cir-cRNAs [32]. As a proof-of-concept, using biochemical, functional, and computational analyses, this study showed that CDR1as, a known human circRNA, can bind miR-7 in neuronal tissues to function as a negative regulator [32].
Interestingly, treating RNAs with RNA exonuclease to deplete linear RNAs, researchers were able to perform bioinformatic analysis to identify complementary ALU repeats in introns; the results showed that circRNAs are abundant and stable RNA splicing products and are not randomly produced, suggesting that circRNAs are truly involved in gene expression regulation [31]. It is worth noting that all these discoveries would not have been made possible without the advancement of HTS technology.

Characterization of circRNAs
Thanks to the efforts from a number of research groups, to date, more than 20,000 different circRNAs have been identified, showing an unprecedented diversity of circRNAs among different species [33]. In addition, tissue and subcellular expression are also characterized. Surprisingly, in mammalians, most circRNAs are found in the brain, mainly in neuronal and synaptic functions [34,35]. In situ sequencing was used to reveal the subcellular localization of cir-cRNAs in the brain and found that as predicted, circRNA transcripts are enriched in the cytoplasm. However, nuclear localization was also found, though to a less extent [36]. Other studies also showed the role of circRNAs to regulate gene expression in the nucleus [4]. In other tissue types, such as the liver, heart, placenta, and blood, circRNAs are also found [36]. Another study not only investigated tissuespecific expression pattern but also explored the role of cir-cRNAs in a development stage-specific manner and found that similar to adult human tissues, fetal tissues show an abundance of circRNAs [37].
Before we discuss the classifications of circRNAs, we will briefly introduce the noncoding RNA (ncRNA) family. As its name suggests, ncRNA is an RNA that is not translated into a protein. ncRNAs mainly consist of transfer RNA, ribosomal RNA (rRNA), and many other small RNAs such as long noncoding RNA (lncRNA: ≥200 nt), small noncoding RNA (sncRNA: 100-200 nt), miRNA (20-24 nt), and endogenous small interfering RNA (endo-siRNA). circRNAs have been categorized as ncRNAs; however, recent new studies challenged this view by demonstrating that circRNAs can code for proteins (Figure 1(d)) [38][39][40]. These studies showed that a group of circRNAs termed ribo-circRNAs, because they are associated with translating ribosomes, are bound by membrane-associated ribosomes, suggesting the existence of unexplored modes of regulation of genes and proteins [38,39]. Another study showed that translation of circRNAs could be driven by m6A, the most abundant RNA modification [41]. Nevertheless, the characterizations of circRNAs have just started.
Stability is one of the distinct characteristics of cir-cRNAs separating them from linear RNAs. In general, compared to linear RNAs, circRNAs are quite stable, because the lack of a poly(A) tail in circRNAs can protect them from exonuclease-mediated degradation [31]. This feature has been utilized to a recent engineering study to generate exogenous circRNAs, thus obtaining more potent and durable proteins in eukaryotic cells [42].

Biogenesis of circRNAs
Linear RNAs usually terminate with 5 ′ caps and 3 ′ tails and undergo canonical splicing; however, due to the closed loop structure, neither 5 ′ -to-3 ′ polarity nor poly(A) tail can be found in circRNAs. Thus, circRNAs show stability over linear RNAs [31,32]. Canonical splicing in pre-mRNAs is catalyzed by a spliceosome assembly, resulting in a linear RNA transcript with a 5 ′ -to-3 ′ polarity. This splicing strategy is considered as highly efficient. Different from canonical splicing, circRNAs are generated via backsplicing, which, on the contrary, is considered as a noncanonical way ( Figure 2). When the upstream 3 ′ splice acceptor site joins with a downstream 5 ′ splice donor site, the junction site is ligated by a 3 ′ -5 ′ phosphodiester bond, resulting in covalently closed cir-cRNAs. The sizes of mature circRNAs have a wide range from~100 nt to 4 kb [43]. In human cells, the most common size is several hundred nucleotides spanning two or three exons [31,44,45]. Besides, long flanking introns comprising inverted repeat sequences have been proved to promote exon circularization [46,47]. Unlike canonical splicing, backsplicing is usually considered as poorly efficient by approximately 1-3% of the former [48,49].

Categories of circRNAs
The RNA research community has annotated four different types of alternative splicing, including (1) intron retention, (2) exon skipping, (3) alternative 5′ splicing, and (4) alternative 3 ′ splicing [50], suggesting the complexity of the biogenesis of circRNAs. Based on these four types of alternative splicing, circRNAs can be categorized into four types: intron-derived circRNAs, exon-derived circRNAs (ecircR-NAs), intergenic circRNAs, and exon-intron circRNAs (elciRNAs) [51]. Among these types, ecircRNAs are predominantly generated from backspliced exons as the largest type of circRNAs, accounting for the majority of the circRNAs that have been discovered.

Major Biological Function and Disease Relevance
In contrast to mRNAs and miRNAs, the biological functions of circRNAs are largely unclear. However, in the last decades, a number of seminar investigations have been conducted to demonstrate a wide variety of roles that circRNAs might play.
Here, we briefly summarize some critical functions that cir-cRNAs are implied to play. CircRNAs can act as miRNA sponges, that is to say, by its name, circRNAs are reservoirs of miRNAs (Figure 1(a)). It is well known that miRNAs belong to a family of ncRNAs that regulate gene expression in a wide range of biological processes. The current view of circRNAs as a miRNA or protein sponge is that circRNAs regulate miRNA activity, thus modulating the expression of miRNA target genes [52]. As illustrated in Figures 1(b) and 1(c), in healthy and tumor tissues, specific circRNAs harbor miRNAs that target different types of genes such as tumor-suppressor genes or oncogenes, thus exhibiting various biological effects. Owing to the importance of miRNAs that bind to circRNA sponges, miRNA-based computational pipelines have been established to predict circRNA targets. We will revisit this topic in a later section of this review. In addition to regulating miRNA, circRNAs also serve as the sponge of RNAbinding proteins (RBPs) to regulate intracellular transport (Figure 1(a)), thereby modulating gene expression of relevant RBPs of interest [53]. Readers with interests in this topic could find more details in several recent reviews [54][55][56]. As shown in Figure 1(a), circRNAs, such as ciRS-7, also bind to Argonaute (AGO) proteins in a miR-7-dependent manner [57], which could regulate mRNA transcription and translation.
A number of circRNAs have been identified as miRNA sponges. A prominent example is ciRS-7, which serves as a miR-7 sponge [32,57]. ciRS-7 is highly expressed in the cytoplasm and has more than 70 miR-7 target sites [57]. It has been reported that ciRS-7 functions as both tumorsuppressor and oncogenic sponges, serving as a promising biomarker for various cancers such as colorectal cancer [58], hepatocellular carcinoma [59], esophageal squamous cell carcinoma [60,61], cervical cancer [62], and pancreatic cancer [63]. Interestingly, some studies also show that ciRS-7 promotes β-amyloid precursor protein (APP) and β-site APP-cleaving enzyme (BACE1) degradation [16]; thus, it might also play a role in Alzheimer's disease.

Bioinformatic Analysis of circRNAs
Given the importance of circRNAs in gene expression regulation, a growing interest emerges in identifying novel cir-cRNAs and understanding their biological functions. Therefore, genome-wide identification and prediction of cir-cRNAs are crucial for the study of circRNA biological functions [115,116]. Effective investigation of circRNAs highlights a particular need of HST technology. In the past years, the highthroughput microarray was a dominating means to study the junction sequences of circRNAs [117,118]. By designing Synaptic transmission, aging, brain development, adult neurogenesis, brain network, sensorimotor gating, etc.   BioMed Research International probes to target specific circular junction sites, a circRNA microarray allows accurate and reliable detection of individual circRNAs. Following a detailed annotation of potential miRNA target sites, a circRNA microarray helps to reveal their potential roles as a miRNA sponge. The isolated RNA samples go through a pretreatment process, in which RNase R is used to remove linear RNAs and improve the purity of circRNAs. However, the limited number of known circRNAs during annotation and the use of a junction sequence to identify circRNAs bring limitations to the application of a microarray. Therefore, in recent years, high-throughput RNA-seq technology has become the dominant approach to identify circRNAs. As a result, a number of computational pipelines for circRNA identification have been developed to identify circRNAs from massive RNA-seq databases.
In this section, we introduce several commonly used computational pipelines for the identification of circRNAs. Figure 4 outlines several key steps in studying circRNAs using publicly available pipelines; thus, readers could have a brief idea of where to choose individual pipelines. We apologize for omitting any key pipelines or key steps. Thus, we highly recommend readers to refer to other reviews specifically on this topic [119][120][121][122]. Table 1 provides a comprehensive summary of online tools for the study of circRNAs, while Table 2 is a list of computational pipelines for optional analysis of circRNAs. To our knowledge, this is the most comprehensive and updated summary of cir-cRNAs tools. In addition, a video-based introduction to the identification of circRNAs from RNA-seq is also available from JOVE [123].
To effectively identify circRNAs, no matter which computational pipeline is used, one needs to discriminate cir-cRNAs from linear RNAs. Several biochemical assays have been developed to distinguish circRNAs from other backsplicing products, including (1) divergent primer PCR, (2) relative migration of circRNAs from a canonical linear RNA in an agarose gel, (3) 2D gel electrophoresis, (4) gel trapping, and (5) exonuclease enrichment [119]. Other than biochemical enrichment strategies, deep sequencing with novel bioinformatics analysis has been developed to perform a comprehensive characterization of circRNAs. To date, candidate-or pseudo-reference-based strategies have been designed in computational pipelines [119,124]. The candidate-based strategy uses a list of candidate junctions that were generated from previous models [1,119]. Thus, this approach is able to analyze rRNA-depleted libraries in a fast manner; however, it has an obvious limitation in unannotated transcripts. Constructing putative circRNA sequences with gene annotation, a pseudo-reference-based approach, such as KNIFE [45], NCLScan [125], and PTES-Finder [126], has become widely used. These approaches use several systematic filtering steps to remove false positive [120,124]. For example, by using PTESFinder to analyze previously mined RNA-seq reads, significantly more distinct structures were found than previously reported (between 13% and 42%), whereas a significant number of reads were excluded by PTESFinder due to low map quality or multiple map locations [126]. Thus, owing to these novel pipelines, the highest specificity and sensitivity could be achieved. In addition to these strategies, a fragmented-based strategy is also frequently used, in which a backsplicing junction is aligned to the genome [120].
Although these detection pipelines could significantly accelerate the identification of novel circRNAs, inconsistency in results might occur when switching from one pipeline to another. Thus, evaluations for different circRNA pipelines had been performed. A recent comparison study has provided a comprehensive and unbiased comparison among several circRNA detection pipelines [120]. This study used a number of measurements to evaluate their performance, including precision, sensitivity, F1 score and area under curve, random access memory consumption, running time, and physical disk space utilization, and concluded that CIRI, CIRCexplorer, and KNIFE have better performance [120]. An earlier review had summarized the criteria in different pipelines or algorithms to perform filtering and accuracy evaluation; thus, we highly recommend readers to refer to this review [127]. In addition, it is worth noting that, as many studies have already pointed out, this study also suggested that no individual pipeline could achieve the best performance among all the metrics used, indicating an urgent need to refine and integrate all these available methods for cir-cRNA detection [128,129]. For the time being, pairing different pipelines possibly produces a much more reliable output, for example, circRNA and find_circ.
To increase the accuracy in circRNA identification, two concerns should be kept in mind when designing experiments: (1) At the experimental stage, many variations can affect circRNA abundances, such as RNA purification, size selection, and RNA fragmentation followed by adaptor ligation. RNase R is commonly used to digest linear RNAs to enrich circRNAs for sequencing, but not all circRNAs are resistant to RNase R; conversely, a few linear RNAs can avoid RNase R digestion. (2) A small fraction of circRNAs inherently exits in common cell lines, which account for approximately 2-4% of the total mRNAs. This level is higher in platelets. Therefore, significant biases will arise when bioinformatic analysis relies on junctional reads. As a result, a high rate of false positives occurs. To this end, most pipelines apply multiple high thresholds on absolute read counts. Other pipelines employ statistical approaches to reduce the reliance on the thresholds.
The current limitations of circRNA research include limited methods available to detect and quantify circRNAs. Although RT-qPCR-based methods are low cost and highly sensitive methods that can be easily applied in many laboratories, they are not high-throughput methods that can detect and quantify circRNAs. While RNA-seq has served as the main method that has high sensitivity and high throughput, the cost can be high, and it usually requires sufficient computational power. A detailed comparison of different methods for circRNA detection and quantification can be found elsewhere [7]. The genome-wide prediction tools, as discussed here, can largely assist in the identification and characterization of circRNAs; however, it is still challenging to assess the circRNA-miRNA and circRNA-protein interactions. In most cases, the sequences of the circRNAs are not clear, which might be problematic for downstream analysis such as  Figure 4: Key steps in studying circRNAs using publicly available pipelines. For read data, the library preparation is similar to traditional mRNA extraction. For stimulated data, several tools such as KNIFE and CIRI-simulator can be used. Alignment methods for linear RNAs, such as STAR and TopHat, are also commonly used for circRNAs, Therefore, a number of professional pipelines shown in Table 1 can be applied for circRNA detection, such as DCC and CIRI. For downstream analysis, other optional pipelines can be employed for different purposes. Finally, several pipelines can be used to check the association of circRNAs and diseases. The authors apologize for omitting any key pipelines or key steps. Illustration was generated using BioRender.    [190] CIRI-AS 2016 Alternative splicing detection https://sourceforge.net/projects/ciri/files/CIRI-AS 07-04-2016 [191] sailfish-cir 2017 Quantification using model-based framework https://github.com/zerodel/Sailfish-cir 05-04-2017 [192] FUCHS 2017 Towards full circRNA characterization https://github.com/dieterich-lab/FUCHS 09-28-2017 [193] CircRNAwrap 2019 Transcript prediction and abundance estimation https://github.com/liaoscience/circRNAwrap 04-19-2019 [194] CIRI-full 2019 Full-length assembly https://sourceforge.net/projects/ciri/ 04-16-2020 [195] circMeta 2020 Genomic feature annotation, differential expression analysis for circRNAs https://github.com/lichen-lab/circMeta 10-01-2019 [196] CIRIquant 2020 Quantification and differential expression analysis https://sourceforge.net/projects/ciri/files/CIRIquant/ 04-16-2020 [197] NA: not applicable. Last access date: 05-25-2020. 10 BioMed Research International miRNA target prediction. In addition, bioinformatic analysis relying on reads spanning the backsplice junction could be problematic because of the biases in read density [127,130]. We envision that future studies could help solve these critical issues.
In sum, although a number of pipelines are available for circRNA research, how to obtain genome-wide detection of circRNAs with high sensitivity and specificity remains a challenge. It is foreseeable that in the future, a comprehensive comparison of these pipelines, as well as a comparison in computational power using publicly available datasets, will become available.

Comprehensive Databases of circRNAs
Other than the computational tools that are used for the detection and identification of circRNAs, it is undoubtedly important that a comprehensive understanding of the association of these identified circRNAs and human diseases is eagerly expected. Therefore, several circRNA databases have been established containing thousands of mammalian circRNAs carefully selected from various sources. Thus, detailed information, such as genome sequence, subcellular location, and disease annotation, are all provided to researchers working on circRNAs. Table 3 summarizes the most updated circRNA databases that are publicly available. Among these databases, several of them are widely used, such as Circ2Traits [131], circBase [132], and circFunBase; they are among the earliest circRNA databases that are commonly used. Here, we briefly discuss how to make full use of CircBase. We suggest that readers find more useful information from other papers [120,132,133].
circBase, as one of the earliest developed databases for circRNAs, was brought in 2014 and has been widely used in the circRNA community [132]. As of today, the original report of circBase has been cited for nearly 600 times, indicating that it has been regarded as a powerful tool for the community [132]. The main aim of developing circBase was to provide summary information of individual circRNAs that have been identified, together with their genomic context. Three ways of searching circBase were provided, including simple search, list search, and table browser search. These searching methods can be easily found on the main page of the website (http://www.circbase.org/). Simple search, with identifiers, genomic coordinates, sequences, gene ontology identifiers, transcript ID, and gene symbols, is the easiest way of searching the database. List search gives users an option to paste or upload a list of several circRNAs or refseq identifiers, as well as gene symbols. Organism is required to be selected. Table browser search is a quick search option based on the browser interface. Note that organism and dataset information is required to be selected. As illustrated in Figure 5(a) as an example, in the circBase table browser page, users could select human as Organism and use a dataset from a previous study [31]. Both sample conditions and annotation allow for multiple selection. After submitting using the search button, a detailed result page will be returned, with basic information on individual circRNAs that matches the query ( Figure 5(b)). The listed information includes organism data source; genomic position information which directs to a link from the UCSC genome browser, with full information on strand; circRNA ID; genomic length; spliced length; list of samples that contain the circRNAs; and number of reads. By clicking a single circRNA, the link will direct the users to a single record page, which contains detailed information on a particular circRNA. Detailed information on how to use circBase can be found on the documentation page (http://www.circbase.org/doc/help_mod.html). In addition, in circBase, data can be exported in standardized formats such as xlsx, txt, csv, or fasta, providing users a variety options to integrate with other analysis tools. In general, cir-cBase is an excellent database that focuses on elementary information of backsplicing junction coordinates.
Here, we are giving the readers another example, circad (circRNAs associated with diseases), a database mainly for disease-associated circRNAs [144]. After submitting a circRNA's name in the browser (http://clingen.igib.res.in/ circad/), the database returns with a selection of different organisms. Selecting one organism will bring users to the next page, which has information including genome locus, gene name, disease association, fold change, and a publication's PubMed ID (PMID). It is worth noting that as an exception to many databases, circad includes detailed information of the primers used in that publication. A detailed documentation on how to use circad can be found (http://clingen.igib.res.in/circad/img/circad.pdf).
In addition, several other databases have also been developed. Here, we provide a brief introduction to each of them (for the web links and last updated data, as well as references for individual databases, please refer to Table 3): (1) circ2Traits is the first comprehensive database of potential disease association of circRNAs in humans [131]; in this database, users can find SNPs associated with diseases and AGO interaction sites (2) SomaniR is a database mainly for cancer somatic mutation in miRNAs and their target sites that might potentially interact with circRNAs [145] (3) CircNet is a database with resources of novel cir-cRNAs, integrated miRNA-target network, expression, annotations, and sequences of circRNA isoforms [146] (4) circRNADb is a human circRNA database that contains more than 32k annotated exonic circRNAs [147] (5) TSCD is an integrated tissue-specific circRNA database, which deposits features of tissue-specific circRNAs [148], and users could find tissuespecific expression in both mouse and human adult and fetus 11 BioMed Research International  [149]; this database contains circRNA annotations across 6 species, including human, mouse, rat, zebrafish, fly, and worm (7) CircR2Disease is a manually curated database that gives users a comprehensive resource for circRNA deregulation in diseases [150]; it contains >700 associations between 661 circRNAs and 100 diseases so that users can study the mechanism of disease-related circRNAs (8) exoRBase is a database that has >58k circRNAs in human blood exosomes, which helps users to identify exosomal biomarkers [151] (9) TRCirc can be used to study transcriptional regulation of circRNAs based on ChIP-seq and RNAseq results [152]; it also enables analysis of methylation level (10) CircRNAdisease is another newly developed database to understand circRNA and disease associations [153]; it contains 354 associations between 330 circRNAs and 48 diseases (11) CircBank is a comprehensive database for human circRNAs, and it contains 5 features such as a miRNA binding site, conservation of circRNAs, m6A modification, mutation, and protein-coding potential of circRNAs [154]; note that this database has a novel naming system for circRNAs (12) circFunbase is a database featured by a highquality functional circRNA resource [155]; most of the resource has been validated by experiments; it contains circRNAs from a wide variety of species, such as plants and animals (human, monkey, rat, mouse, etc.) (13) LncACTdb is a database mainly for endogenous RNAs such as circRNAs in different species and diseases [156]; it contains about 60 experimentally supported circRNA interactions (14) CropCircDB is a database specifically for crop cir-cRNAs such as maize and rice [157]; it also has validated crop circRNAs in response to abiotic stress (15) AtCircDB is another plant-specific database mainly for Arabidopsis circRNAs [158] (16) MiOncoCirc is a database that contains circRNAs from cancer cell lines and tumor samples [23] (17) Circad is another disease-associated database for circRNAs [144]; it has >1300 circRNAs implicated with 150 diseases; besides, it has circRNAs from 5 species, including human, rat, and mouse (18) ncrpheno is a database mainly for ncRNAs; however, it contains 848 circRNAs as well as circRNArelated diseases [159] (19) NPInter (v4) is the 4th version of the NPInter database that integrates 6M newly identified ncRNA interactions including circRNA interactions [160]; it also contains circRNAs from dozens of species, including human, mouse and rat (20) CircAtlas (v2) is a database that integrated 1M cir-cRNAs across 6 species, including human, macaca, mouse, rat, pit, and chicken as well as 19 normal different tissues [161]; it also describes a conservation score, coexpression, and regulatory networks (21) VirusCircBase is a comprehensive database of viral circRNAs [162]; it contains 12K circRNAs, most in viruses and infectious diseases To our knowledge, this summary list is the most updated summary of circRNA databases. Here, we recommend the following principles for readers to choose each database based on the purposes of their experiment and analysis: (1) Disease association: for projects that are aimed at comparing several disease conditions, these databases could be chosen-circ2Traits, circR2Disease, cir-cRNAdisease, Circad, ncrpheno, and CircAtlas (2) Cross-species comparison: for projects involving a cross-species comparison, these databases contain circRNA information on several different species, including CIRCpedia, circFunbase, Circad, NPInter (v4), and CircAtlas (v2) (3) Transcriptomic regulation: for projects that are aimed at studying epigenetic regulation of gene expression, these databases could be chosen-TRCirc, CircBank, LncACTdb, and NPInter (v4) (4) Tissue-specific purpose: for projects that are aimed at comparing circRNAs in a wide range of normal tissues. The databases that could fulfill this purpose are TSCD, NPInter (v4), and CircAtlas (v2). Nevertheless, it is advised to perform an initial search via exoRBase for a blood-related project, whereas Virus-CircBase should be the first choice for a virus-related project. However, it is always preferable to go through each relevant database if necessary.

Concluding Remarks
In the past few years, growing evidence has been seen in circRNAs as potential diagnostic and prognostic biomarkers for human diseases. Because most circRNAs are abundantly expressed in a wide variety of tissue types and cell types, and that circRNAs show great stability and a robust regulation role in gene expression, circRNAs will become favorable biomarker candidates that are worthy of investigation in both basic and clinical medical sciences. One of the bottlenecks in studying circRNAs is detection and identification from genome-wide datasets. The emerging field of big data enables us an unprecedented opportunity to store, manage, process, and analyze biological data 14 BioMed Research International that contains information with tremendous complexity. Therefore, a computational strategy that mainly uses publicly available pipelines and databases developed and shared by circRNA communities could enormously reduce the challenges and increase the efficiency of applying bioinformatics knowledge to identify key circRNAs that could bring diagnostic and prognostic values.
In this review, we have briefly introduced the biology of circRNAs, including characteristics, biogenesis, biological functions, and disease relevance, as well as several computational approaches that enable researchers to detect and identify potential novel circRNAs. Finally, we have highlighted several publicly available computational resources for the analysis of circRNAs that, to our knowledge, are the most completed and updated. Thus, we hope this review will help researchers at various levels in their current and future studies on circRNAs.
The study of circRNAs has just begun, and the field is relatively young. A number of outstanding questions are still waiting to be addressed, such as the association of circRNAs in disease progression and development, the value of circulating circRNAs to predict their abundance and relevance in deep tissues, novel functions of circRNAs beyond sponges for small molecules, and the efficiency of combining singlemolecule HTS technology with circRNAs [34,51,119,163]. Nevertheless, the continuous efforts in detection, identification, and characterization of circRNAs will lead to our understanding of circRNAs' function and clinical value into a completely new lever.

Disclosure
The work described here has not been published before, and it is not under consideration for publication anywhere else. Its publication has been approved by all coauthors, as well as by the responsible authorities, if any-tacitly or explicitly-at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Conflicts of Interest
The authors declare that they have no conflicts of interest.